Skip to main content

Table 1 Baseline characteristics of study subjects

From: Pattern and predictors of immunologic recovery in HIV infected patients

  Health institution, n (%)
KATH SGH Total
Gender Female 67 (67.0 %) 92 (80.7) 159 (74.3)
Age (median, IQR) 38 (33–45) 35 (31–42) 37 (32–43)
Educational levels
 None 16 (19.0) 0 (0.0) 16 (8.1)
 Primary 49 (58.3) 77 (67.5) 126 (63.6)
 Secondary 11 (13.1) 7 (6.1) 18 (9.1)
 Tertiary 8 (9.5) 30 (26.3) 38 (19.2)
Economic status
 Low 71 (86.6) 86 (75.4) 157 (80.1)
 Medium 10 (12.2) 22 (19.3) 32 (16.3)
 High 1 (1.2) 6 (5.3) 7 (3.6)
Primary caregiver
 Spouse 21 (25) 43 (37.7) 64 (32.3)
 Relatives 34 (40.5) 57 (50) 91 (46)
 Self 25 (29.8) 4 (3.5) 29 (14.6)
 Others 4 (4.8) 10 (8.8) 14 (7.1)
Drug
 Azidovudine/lamivudine + NNRTI 39 (50.6) 21 (18.4) 60 (31.4)
 Azidovudine/lamivudine + PI 0 (0) 18 (15.8) 18 (9.4)
 Stavudine/lamivudine + NNRTI 21 (27.3) 74 (64.9) 95 (49.7)
 Others 17 (22.1) 1 (0.9) 18 (9.4)